Cinven agrees to acquire Theramex from Carlyle and PAI Partners
CG•Cinven has agreed to acquire women's health specialty pharmaceutical company Theramex from Carlyle and PAI Partners. Theramex operates in more than 80 countries, and its treatments have reached more than six million women worldwide.
1. Acquisition agreed
Cinven has agreed to acquire Theramex, a women's health specialty pharmaceutical company, from Carlyle and PAI Partners. The investment will support expansion in existing and new markets and further licensing deals to broaden treatment access.
2. Theramex operations
London-based Theramex operates in more than 80 countries, and its treatments have reached more than six million women worldwide.
